OpenIO: An open framework for AI-native immunotherapy.
Journal:
Cancer cell
Published Date:
Jun 25, 2026
Abstract
We propose Open Immune Oncology (OpenIO), a framework integrating generative AI and omics to advance precision oncology. By leveraging biological scaling laws and foundation models, we aim to transition immunotherapy from empirical screening to rational, AI-native engineering of therapeutic interventions.
Authors
Keywords
No keywords available for this article.
